San Juan Oncology Associates — Farmington, New Mexico

San Juan Oncology Associates is a clinical research site located in Farmington, New Mexico, United States 87401.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

San Juan Oncology Associates has participated in 61 clinical trials with 12 currently active.

Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Non-small Cell Lung Cancer (NSCLC), mCRPC.

Sponsors: Pfizer, Hoffmann-La Roche, Janssen Research & Development, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Farmington

Browse all research sites in New Mexico · View every site in Farmington

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for San Juan Oncology Associates?

San Juan Oncology Associates has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has San Juan Oncology Associates conducted?

San Juan Oncology Associates has 61 clinical trials on record, with 12 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Non-small Cell Lung Cancer (NSCLC), mCRPC.

Is San Juan Oncology Associates accredited by Crixeo Clinical Trials?

San Juan Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about San Juan Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.